Sonoma Pharmaceuticals (SNOA) Revenue Growth (5y) (2015 - 2026)
Sonoma Pharmaceuticals (SNOA) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 1.92 Mn | -477,555.95 | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.85% |
| Dec 31, 2025 | -2.50% |
| Sep 30, 2025 | -0.58% |
| Jun 30, 2025 | -6.99% |
| Mar 31, 2025 | -2.73% |
| Dec 31, 2024 | -4.11% |
| Sep 30, 2024 | -5.41% |
| Jun 30, 2024 | -5.48% |
| Mar 31, 2024 | -4.73% |
| Dec 31, 2023 | -9.88% |
| Sep 30, 2023 | -11.17% |
| Jun 30, 2023 | -4.74% |
| Mar 31, 2023 | -3.78% |
| Dec 31, 2022 | -9.48% |
| Sep 30, 2022 | -5.09% |
| Jun 30, 2022 | 0.76% |
| Mar 31, 2022 | -10.62% |
| Dec 31, 2021 | 73.05% |
| Sep 30, 2021 | 6.00% |
| Jun 30, 2021 | 6.91% |